MITOCHONDRIAL DISORDERS AND THEIR CORRECTION IN NEUROLOGICAL DISEASES

被引:0
|
作者
Sidorova, Olga [1 ]
机构
[1] Moscow Reg Res Clin Inst MONIKI, Moscow, Russia
来源
关键词
Sense of belonging; Scale; Adolescents; IDEBENONE; EFFICACY;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Mitochondria are cellular organelles that produce energy in the form of ATP. For this reason, they are called "power stations" or "energy factories". Mitochondria have their DNA. Part of mitochondrial DNA in the process of phylogenesis moved into nuclear DNA. There are 4 types of metabolism in mitochondria: a) Transfer of electrons in the respiratory chain with the formation of ATP and oxygen, b) Fat metabolism with the participation of carnitine, c) Amino acid metabolism, d) Carbohydrate metabolism. There are 2 groups of mitochondrial pathology: Primary mitochondrial pathology is hereditary syndromes caused by mutations in genes responsible for mitochondrial proteins (Kearns-Sayre syndrome, Pearson syndrome, MELAS syndrome, MERRF syndrome, and others). Secondary mitochondrial pathology includes dysfunction of mitochondria as an important link in pathogenesis. Primary mitochondrial diseases are caused by mutations in mitochondrial DNA or nuclear DNA that affect the respiratory chain or mtDNA homeostasis. Secondary mitochondrial disorders have been identified in common sporadic neurological diseases, including Alzheimer's disease, Parkinson's disease, and other pathologies.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [31] Sleep Disorders in Mitochondrial Diseases
    Valerio Brunetti
    Giacomo Della Marca
    Serenella Servidei
    Guido Primiano
    Current Neurology and Neuroscience Reports, 2021, 21
  • [32] Sleep Disorders in Mitochondrial Diseases
    Brunetti, Valerio
    Della Marca, Giacomo
    Servidei, Serenella
    Primiano, Guido
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (07)
  • [33] IATROGENIC NEUROLOGICAL - DISEASES DRUG-INDUCED NEUROLOGICAL DISORDERS
    SPILLANE, JD
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1964, 57 (02): : 135 - 140
  • [34] Nitric Oxide and Mitochondrial Function in Neurological Diseases
    Ghasemi, Mehdi
    Mayasi, Yunis
    Hannoun, Anas
    Eslami, Seyed Majid
    Carandang, Raphael
    NEUROSCIENCE, 2018, 376 : 48 - 71
  • [35] Mitochondrial neurological diseases: A clinician's perspective
    Venna, N
    NEUROLOGY INDIA, 2004, 52 (03) : 305 - 306
  • [36] Mitochondrial protein dysfunction in pathogenesis of neurological diseases
    Wang, Liang
    Yang, Ziyun
    He, Xiumei
    Pu, Shiming
    Yang, Cheng
    Wu, Qiong
    Zhou, Zuping
    Cen, Xiaobo
    Zhao, Hongxia
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [37] An overview of neurological and neuromuscular signs in mitochondrial diseases
    Chaussenot, A.
    Paquis-Flucklinger, V.
    REVUE NEUROLOGIQUE, 2014, 170 (05) : 323 - 338
  • [38] The Role of Mitochondrial Pyruvate Carrier in Neurological Disorders
    Liu, Yue
    Yu, Xiying
    Jiang, Wei
    MOLECULAR NEUROBIOLOGY, 2025, 62 (03) : 2846 - 2856
  • [39] Mitochondrial dysfunction in neurological disorders with epileptic phenotypes
    Zsurka, Gabor
    Kunz, Wolfram S.
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2010, 42 (06) : 443 - 448
  • [40] Implications of mitochondrial dysfunction in common neurological disorders
    Larsson, N. G.
    JOURNAL OF NEUROLOGY, 2007, 254 : 4 - 5